OnTrackNY's Learning Healthcare System
NCT04021719 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 2100
Last updated 2026-02-04
Summary
This application proposes OnTrackNY as a regional scientific hub for the Early Psychosis Intervention Network (EPINET) program as part of the National Institute of Mental Health (NIMH)'s creation of a national learning health care system (LHS) for early psychosis care. OnTrackNY has grown into a 22-site network, under the leadership of Lisa Dixon, MD, MPH.
Created and supported by the New York State's Office of Mental Health (OMH), OnTrackNY is a nationally recognized model providing coordinated specialty care (CSC) for adolescents and young adults within two years of the onset of non-affective psychosis. OMH regulates and licenses all mental health programs in New York and is a direct-services provider via state-operated programs statewide. This makes OMH an ideal partner for establishing a statewide learning health care system for early psychosis care. Further, OnTrackNY's administration, OnTrackCentral, operates within the OMH-supported Center for Practice Innovations at Columbia Psychiatry. In this model, OnTrackCentral serves as the hub and the 22 OnTrackNY programs serve as the spokes. Since 2014, the still-growing OnTrackNY network has served over 1,600 individuals. From its inception, OnTrackNY has aimed to deliver high-quality, data-driven, accountable and culturally competent care consistent with an LHS. As a condition of funding, all OnTrackNY providers follow established protocols that require submission of patient- and site-level standard measures of early psychosis clinical features, services, and treatment outcomes.
The proposed EPINET regional hub, the OnTrackNY LHS, will emphasize and enhance two critical foundational components - Aim 1: proactively engage stakeholders to optimize understanding of key problems and their solutions at every LHS phase; and Aim 2: develop data systems with enhanced standardized data collection, including post-discharge data and linkages to external data systems, and enhancing data analytics that will allow for client-level treatment planning and prospective analytics, delivering real time, dynamic and actionable information to stakeholders. These LHS components do not follow in a stepwise sequence but instead operate in parallel and interact to facilitate and enhance quality improvement processes. This backbone will support the development of practice-based research.
Conditions
- First Episode Psychosis
Interventions
- OTHER
-
Stakeholder feedback
Stakeholders, including OnTrackNY participants, past participants, family members, clinicians, administrators, payors and state leadership, will participate in a variety of activities to provide continuous quality improvement to the OnTrackNY program, including a Stakeholder Workgroup, interviews and focus groups
- OTHER
-
Data infrastructure
Data will be systematically collected as part of CQI activities, within a state-of-the-art data infrastructure that allows for client-level feedback to clients, providers and sites to improve quality of care.
Sponsors & Collaborators
- collaborator OTHER
-
New York University
collaborator OTHER -
Washington University School of Medicine
collaborator OTHER -
National Institute of Mental Health (NIMH)
collaborator NIH -
New York State Psychiatric Institute
lead OTHER
Principal Investigators
-
Lisa B Dixon, MD, MPH · New York State Psychiatric Institute
-
Iruma Bello, PhD · New York State Psychiatric Institute
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-15
- Primary Completion
- 2026-12-30
- Completion
- 2026-12-30
Countries
- United States
Study Locations
More Related Trials
-
Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents
NCT00057681 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment and Outcome of Early Onset Bipolar Disorder
NCT00048802 ·Status: COMPLETED ·Phase: PHASE4
-
Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation
NCT00801567 ·Status: WITHDRAWN ·Phase: NA
-
Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression
NCT01051440 ·Status: TERMINATED ·Phase: PHASE4
-
Pediatric Open-Label Extension Study
NCT01914393 ·Status: COMPLETED ·Phase: PHASE3
-
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
NCT02893371 ·Status: TERMINATED
-
The Bipolar Lithium Imaging Scan Study.
NCT06134349 ·Status: RECRUITING
-
Early Detection and Prevention of Mood Disorders in Children of Parents With Bipolar Disorder
NCT00338806 ·Status: COMPLETED ·Phase: NA
-
DELPhI Evaluation of Psychiatric Conditions
NCT03842345 ·Status: WITHDRAWN
-
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
NCT01212588 ·Status: TERMINATED ·Phase: PHASE2
-
Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder
NCT00592358 ·Status: TERMINATED ·Phase: PHASE4
-
Event Marker Ingested To Trigger Event Recorder 3.0 Psychiatry Study
NCT01804257 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of the Effects of Circadian Rhythms on the Treatment of Bipolar I Depression.
NCT00726154 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression
NCT01093963 ·Status: TERMINATED ·Phase: PHASE3
-
Spectroscopy in Children and Adolescents With Bipolar Disorder
NCT00181831 ·Status: COMPLETED
-
Peroxisomal Defects and Familial Risk for Bipolar Disorder
NCT01237379 ·Status: COMPLETED
-
INP105 Proof-of-concept Study for the Acute Treatment of Agitation in Adolescents and Young Adults With ASD
NCT05163717 ·Status: TERMINATED ·Phase: PHASE2
-
Retrain Your Brain in Children/Adolescents With Bipolar Disorder: A Pilot Study
NCT01954680 ·Status: UNKNOWN ·Phase: PHASE1
-
Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults
NCT00218114 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Therapy for the Treatment of Bipolar Disorders
NCT00063362 ·Status: TERMINATED ·Phase: PHASE3
-
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
NCT01131559 ·Status: TERMINATED ·Phase: PHASE3
-
Maternal And Infant Antipsychotic Study
NCT06049953 ·Status: RECRUITING
-
Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
NCT00181727 ·Status: COMPLETED ·Phase: PHASE4
-
Bipolar Disorder in Late Life
NCT00787930 ·Status: COMPLETED
-
Exosome for Early Diagnosis of Bipolar Affective Disorder
NCT05915312 ·Status: UNKNOWN